Synamics Therapeutics ApS
Private limited companyCVR 44258048København ØActive
Synamics Therapeutics ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2023. Equity was negative at the end of 2025 (−DKK 115k). The company made a loss in both 2024 and 2025, most recently DKK 588k. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 1.6m to DKK 588k (2024 → 2025).
- Equity turned negative: −DKK 115k (2024 → 2025).
Employees
- 1 more employees than a year earlier: 3 (04/2026) against 2 (04/2025).
Management and owners, last 24 months
- New owners registered: Synamics Therapeutics Inc. (20/02/2025) and Lille Frederikslund Tech Invest ApS (30/12/2024).
- No longer registered as owner: Albert Jelke Kooistra (20/02/2025), Lille Frederikslund Invest ApS (30/12/2024) and Helder Takashi Imoto Nakaya (20/02/2025) (+4).
Registrations, last 24 months
- 25/03/2025: Share capital changed from 50,000 DKK to 50,735 DKK
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | – | −1,695 | 129 | +107.6% |
| Operating profit (EBIT) | 0 | −1,985 | −761 | +61.7% |
| Profit before tax | 0 | −1,996 | −749 | +62.5% |
| Net profit | 0 | −1,554 | −588 | +62.1% |
| Total assets | 40 | 3,550 | 748 | −78.9% |
| Equity | 40 | 473 | −115 | −124.3% |
| Liabilities | 0 | 2,960 | 859 | −71% |
| Cash and cash equivalents | – | 3,022 | 82 | −97.3% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 115k at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 2 years in a row
Net result has been negative in 2024–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 30/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 11/07/2025 | The company | PDF not statedXBRL |
| 2023 | 24/08/2023 – 31/12/2023 | 24/05/2024 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 60,570of 69,742 Better than 13% | No. 62,560of 69,964 Better than 11% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 169of 323 Better than 48% | No. 225of 329 Better than 32% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 14,222of 16,614 Better than 14% | No. 14,111of 16,661 Better than 15% |
| All companies of type ApS66,508 companies in the comparison | No. 58,252of 66,379 Better than 12% | No. 58,909of 66,505 Better than 11% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Synamics Therapeutics ApSDKK 129k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Synamics Therapeutics ApS−DKK 588k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Synamics Therapeutics ApS−DKK 115k
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Synamics Therapeutics ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Synamics Therapeutics Inc.100%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Violet Zahedi | Director | 24/08/2023 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Violet Zahedi | Board member | 24/08/2023 |
| Aaron Daniel Capar | Chair of the board | 24/08/2023 |
| Albert Jelke Kooistra | Board member | 24/08/2023 |
| Per Falholt | Board member | 09/07/2024 |
- Founders
- Albert Jelke Kooistra, Helder Takashi Imoto Nakaya, Continuum Holdings Inc.
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Helder Takashi Imoto Nakaya | Board member | 24/08/2023 | 09/07/2024 |
Signing rule: Selskabet tegnes af en direktør sammen med bestyrelsesformanden eller af den samlede bestyrelse
Address and production units
1 active production unitsFruebjergvej 3
2100 København Ø
København Municipality · Postcode 2100
Other companies at the address (8)
- Vektor Ejendomme A/SBuying and selling of own real estate
- Symbion A/SRenting of commercial property
- Synopsys Denmark ApSComputer consultancy and computer facilities management
- Clinical-Microbiomics A/SResearch and experimental development on natural sciences and engineering
- River Stone Biotech ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Synamics Therapeutics ApS | Fruebjergvej 3, 2100 København Ø | 3 | 1029580681 |
Purpose
Selskabets formål er at fremskynde opdagelsen af lægemidler gennem udvikling af kunstig intelligens og maskinlæring og at identificere nye forbindelser og mål
The purpose is quoted from the register in Danish.
Changes year by year
41 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
202510 changesaccounts 1 · capital 1 · ownership 7 · industry 1
- AccountsAnnual report for 2024 published
- CapitalShare capital changed from 50,000 DKK to 50,735 DKK
- OwnershipSynamics Therapeutics Inc. registered as owner (100%)
- OwnershipLille Frederikslund Tech Invest ApS is no longer registered as owner
- OwnershipViolhuset ApS is no longer registered as owner
- OwnershipAlbert Jelke Kooistra is no longer registered as owner
- OwnershipHelder Takashi Imoto Nakaya is no longer registered as owner
- OwnershipContinuum Holdings Inc. is no longer registered as owner
- OwnershipXivius LLC is no longer registered as owner
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202420 changesownership 15 · address 1 · capital 1 · management 2 · accounts 1
- OwnershipLille Frederikslund Tech Invest ApS registered as owner (10%)
- OwnershipLILLE FREDERIKSLUND INVEST ApS is no longer registered as owner
- OwnershipViolhuset ApS registered as owner (10%)
- OwnershipSteen Riisgaard is no longer registered as owner
- AddressMoved to Fruebjergvej 3, 2100 København Ø
- CapitalShare capital changed from 40,000 DKK to 50,000 DKK
- ManagementPer Falholt appointed board member
- ManagementHelder Takashi Imoto Nakaya stepped down as board member
- OwnershipLILLE FREDERIKSLUND INVEST ApS registered as owner (10%)
- OwnershipSteen Riisgaard registered as owner (10%)
- OwnershipAlbert Jelke Kooistra registered as owner (10%)
- OwnershipHelder Takashi Imoto Nakaya registered as owner (10%)
- OwnershipContinuum Holdings Inc. registered as owner (25%)
- OwnershipXivius LLC registered as owner (25%)
- OwnershipXivius LLC is no longer registered as owner
- OwnershipHelder Takashi Imoto Nakaya is no longer registered as owner
- OwnershipAlbert Jelke Kooistra is no longer registered as owner
- OwnershipContinuum Holdings Inc. is no longer registered as owner
- OwnershipXivius LLC registered as owner (33.33%)
- AccountsAnnual report for 2023 published
202310 changesaddress 1 · founded 1 · management 5 · ownership 3
- AddressMoved to Tuborg Havnepark 18, 2. th, 2900 Hellerup
- FoundedRegistered as Synamics Therapeutics ApS
- ManagementHelder Takashi Imoto Nakaya appointed board member
- ManagementViolet Zahedi appointed director
- ManagementViolet Zahedi appointed board member
- ManagementAaron Daniel Capar appointed chair of the board
- ManagementAlbert Jelke Kooistra appointed board member
- OwnershipHelder Takashi Imoto Nakaya registered as owner (15%)
- OwnershipAlbert Jelke Kooistra registered as owner (15%)
- OwnershipContinuum Holdings Inc. registered as owner (33.33%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Novo Nordisk A/Svia Steen Riisgaard
- Novozymes A/Svia Per Falholt
- Danfoss A/Svia Per Falholt
- Alk-abelló A/Svia Steen Riisgaard
- Rockwool A/Svia Steen Riisgaard
- Co-ro A/Svia Per Falholt
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.